Cannabis Stock Gainers And Losers From November 1, 2024
Portfolio Pulse from Benzinga Insights
On November 1, 2024, several cannabis stocks experienced significant price changes. Notable gainers included Australis Capital, CordovaCann, and Cara Therapeutics, while major losers included Cann Group, Greenlane Holdings, and Canopy Growth.
November 01, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cara Therapeutics shares rose by 9.40% to $0.29, indicating positive investor sentiment.
Cara Therapeutics' stock price increase suggests positive investor sentiment, possibly due to favorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Canopy Growth shares decreased by 6.10% to $4.95, indicating a decline in investor confidence.
The decrease in Canopy Growth's stock price suggests a decline in investor confidence, possibly due to market trends or company-specific issues.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Cronos Group shares fell by 3.65% to $2.11, showing a slight negative trend.
The slight decrease in Cronos Group's stock price indicates a negative trend, possibly due to broader market conditions.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Greenlane Holdings shares fell by 18.75% to $3.04, reflecting negative market sentiment.
The significant drop in Greenlane Holdings' stock price suggests negative investor sentiment, possibly due to unfavorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
SNDL shares decreased by 4.05% to $2.14, reflecting a minor decline in market sentiment.
The minor decline in SNDL's stock price suggests a slight negative shift in market sentiment, possibly influenced by industry trends.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60